Page 7 - Read Online
P. 7
Cancer Drug Resistance
CONTENTS
Topic: Recent advances in Tumor-Targeting Chemotherapy Drugs
1 Recent advances in tumor-targeting chemotherapy drugs
Iwao Ojima
Cancer Drug Resist 2021;4:885-887 http://dx.doi.org/10.20517/cdr.2021.86
2 Evaluation of the reducing potential of PSMAcontaining endosomes by FRET imaging
Chelvam Venkatesh, Jiayin Shen, Karson S. Putt, Philip S. Low
Cancer Drug Resist 2021;4:223-232 http://dx.doi.org/10.20517/cdr.2020.84
3 Emerging RAS-directed therapies for cancer
Michael Conroy, Darren Cowzer, Walter Kolch, Austin G. Duffy
Cancer Drug Resist 2021;4:543-558 http://dx.doi.org/10.20517/cdr.2021.07
4 Protective autophagy by thymidine causes resistance to rapamycin in colorectal cancer cells in
vitro
I.V. Bijnsdorp, Godefridus J. Peters
Cancer Drug Resist 2021;4:719-727 http://dx.doi.org/10.20517/cdr.2021.21
5 Cost-effectiveness of Osimertinib in activating epidermal growth factor receptor gene (EGFR)-
mutations in first-line for advanced non-small cell lung cancer
Jacopo Giuliani, Andrea Bonetti
Cancer Drug Resist 2021;4:740-744 http://dx.doi.org/10.20517/cdr.2021.14
6 Advances in preclinical evaluation of experimental antibody-drug conjugates
Scott K. Lyons, Dennis Plenker, Lloyd C. Trotman
Cancer Drug Resist 2021;4:745-754 http://dx.doi.org/10.20517/cdr.2021.37
